These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11846151)

  • 1. Continuous improvements in national leucodepletion outcome and potential cause of leucodepletion failure.
    Seghatchian J; Beckman N
    Transfus Apher Sci; 2001 Dec; 25(3):221-4. PubMed ID: 11846151
    [No Abstract]   [Full Text] [Related]  

  • 2. Leucodepletion and immune response mechanisms.
    Semple JW
    Vox Sang; 2004 Jul; 87 Suppl 2():136-8. PubMed ID: 15209898
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of leucodepletion failure in Cobe spectra plateletpheresis: further studies on the identification of the potential cause.
    Seghatchian J; Beard MJ; Krailadsiri P
    Platelets; 2001 Aug; 12(5):302-8. PubMed ID: 11487383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucodepletion, bacterial contamination and viral inactivation: a Portuguese blood centre experience.
    Vasconcelos E
    Transfus Apher Sci; 2001 Dec; 25(3):215-6. PubMed ID: 11846148
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the improvement of leucodepletion performance of the Haemonetics MCS+ for production of leucodepleted platelet concentrate.
    Seghatchian J; Beard MJ; Krailadsiri P
    Platelets; 2001 Aug; 12(5):298-301. PubMed ID: 11487382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective or universal leucodepletion: the Italian experience.
    Accorsi P; Iacone A
    Transfus Sci; 2000; 22(1-2):65-7. PubMed ID: 10771386
    [No Abstract]   [Full Text] [Related]  

  • 7. [Quality control of blood components by means of flow cytometers].
    Gilli R; Truschnig-Wilders M; Beaufort F; Lanzer G
    Beitr Infusionsther Transfusionsmed; 1994; 32():394-6. PubMed ID: 9480131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Centrifugal leukocytapheresis and thrombocytapheresis: recommendations concerning donor safety, quality control of the prepared concentrate, and use of equipment.
    J Clin Apher; 1983; 1(3):117-195. PubMed ID: 6546050
    [No Abstract]   [Full Text] [Related]  

  • 9. [Group for the Study of Immunohematology and Hemotherapy. Norms for the selection and care of platelet and granulocyte donors for pheresis technics].
    Puig LL; Gelabert A; Durán-Suárez JR
    Sangre (Barc); 1984; 29(4-A):473-4. PubMed ID: 6505932
    [No Abstract]   [Full Text] [Related]  

  • 10. What has universal leucodepletion given us: evidence from clinical trials?
    van de Watering L
    Vox Sang; 2004 Jul; 87 Suppl 2():139-42. PubMed ID: 15209899
    [No Abstract]   [Full Text] [Related]  

  • 11. Leucodepletion and regulatory aspects in Germany.
    Heiden M; Keller-Stanislawski B
    Transfus Sci; 2000; 22(1-2):69-70. PubMed ID: 10771387
    [No Abstract]   [Full Text] [Related]  

  • 12. Universal leucodepletion: an overview of some unresolved issues and the highlights of lessons learned.
    Seghatchian J
    Transfus Apher Sci; 2003 Oct; 29(2):105-17. PubMed ID: 12941346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Universal leucodepletion to reduce the risk of transmission of new-variant Creutzfeldt-Jakob disease.
    Sivakumaran M
    Br J Haematol; 2000 Jul; 110(1):234. PubMed ID: 10991551
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluating leucodepletion systems suitable for routine use.
    Rowe G
    Transfus Sci; 2000; 22(1-2):61-2. PubMed ID: 10771384
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of a new WBC-reduction system and the standard plateletpheresis protocol in the same donors.
    Zingsem J; Zimmermann R; Weisbach V; Glaser A; Bunkens H; Eckstein R
    Transfusion; 2001 Mar; 41(3):396-400. PubMed ID: 11274597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quality of MCS+ version C2 double dose platelet concentrate with leucodepletion through a continuous filtration process.
    Seghatchian J; Krailadsiri P
    Transfus Apher Sci; 2002 Feb; 26(1):37-41. PubMed ID: 11931376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leucodepletion (LD) trends and preferred approaches.
    Rowe G
    Transfus Apher Sci; 2001 Dec; 25(3):219-20. PubMed ID: 11846150
    [No Abstract]   [Full Text] [Related]  

  • 18. Leucodepletion, bacterial testing and pathogen removal update and position for Scotland: April 2001.
    Prowse CV
    Transfus Apher Sci; 2001 Dec; 25(3):217-8. PubMed ID: 11846149
    [No Abstract]   [Full Text] [Related]  

  • 19. A flow cytometric method for detection and enumeration of low-level, residual red blood cells in platelets and mononuclear cell products.
    Santana JM; Dumont LJ
    Transfusion; 2006 Jun; 46(6):966-72. PubMed ID: 16734813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of in process qualification in quality improvement of the haemonetics MCS plus leucodepleted platelet concentrate.
    Seghatchian J; Beard M; Krailadsiri P
    Transfus Sci; 2000 Jun; 22(3):165-9. PubMed ID: 10831919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.